Clinical trial
Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer
NCT00416871 · Centre Leon Berard, Other · Completed
Key facts
| NCT number | NCT00416871 |
|---|---|
| Title | Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer |
| Official title | Cytokines in the Treatment of Metastatic Renal Cell Carcinoma (MRCC): Intravenous Interleukin and Subcutaneous Interferon-α Versus Subcutaneous Interleukin and Interferon-α for Good Prognosis Patients [PERCY DUO] |
| Lead sponsor | Centre Leon Berard, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological |
| Interventions | aldesleukin, recombinant interferon alfa |
| Enrollment | 220 |
| Completion | Feb 1, 2006 |
| First posted | Dec 28, 2006 |
| Last update posted | Sep 26, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: